-
OSTX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
OS Therapies (OSTX)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.86 mm | 1.86 mm | ||||
Cash burn (monthly) | (no burn) | 812.46 k | ||||
Cash used (since last report) | n/a | 4.30 mm | ||||
Cash remaining | n/a | -2.44 mm | ||||
Runway (months of cash) | n/a | -3.0 |
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 280.00 k |
Total shares | 100.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Armstrong Advisory | 100.00 | $280.00 k |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Feb 25 | Paul A. Romness | Common Stock, par value $0.001 per share | Other | Acquire J | No | No | 0 | 225,000 | 0.00 | 2,473,000 |
27 Feb 25 | Shalom Auerbach | Common Stock, par value $0.001 per share | Other | Dispose J | Yes | No | 1.64 | 225,000 | 369.00 k | 2,806,211 |
14 Feb 25 | Shalom Auerbach | Common Stock, par value $0.001 per share | Sell | Dispose S | Yes | No | 2.843 | 100,000 | 284.30 k | 2,431,211 |
15 Jan 25 | Shalom Auerbach | Common Stock, par value $0.001 per share | Sell | Dispose S | Yes | No | 6.735 | 16,720 | 112.61 k | 2,531,211 |